Search

866-361-3032

Dec. 7 - FDA Seeks Input on Communication of Drug Safety Information

Posted Date: 
Wednesday, December 7, 2005

As part of the Food and Drug Administration's continued commitment to improve communication about risks posed by prescription medications, its Center for Drug Evaluation and Research (CDER) is holding a public meeting today to evaluate current practices and to explore new tools and strategic partnerships to enhance future efforts.

"In the past year we have made significant strides in alerting healthcare professionals and their patients of emerging risks associated with prescription medications," said Andrew von Eschenbach, MD, Acting FDA Commissioner. "We intend to use the public feedback we receive at this meeting to advance our understanding of the effectiveness of our current efforts and to develop new tools to hone our ability to inform the public."

Source

Testimonial

We're often asked by our clients to meet next-to-impossible deadlines, which means that we're often forced to ask our vendors for the impossible. Working with Nexreg makes my job easier. They are experts at what they do, they pay attention to detail, and they make suggestions and offer advice – which makes us look like the experts. For regulatory compliance and translations, Nexreg ranks as one of the strategic partners we can always count on.
John S. Wolowiec, Zoltun Design